Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Cerus Corporation
Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.
IPO Date: January 31, 1997
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $246.6M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.12 | 2.74%
Avg Daily Range (30 D): $0.05 | 3.32%
Avg Daily Range (90 D): $0.05 | 3.24%
Institutional Daily Volume
Avg Daily Volume: .74M
Avg Daily Volume (30 D): 1.23M
Avg Daily Volume (90 D): 1.28M
Trade Size
Avg Trade Size (Sh.): 178
Avg Trade Size (Sh.) (30 D): 213
Avg Trade Size (Sh.) (90 D): 213
Institutional Trades
Total Inst.Trades: 941
Avg Inst. Trade: $1.28M
Avg Inst. Trade (30 D): $1.09M
Avg Inst. Trade (90 D): $1.13M
Avg Inst. Trade Volume: .24M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.27M
Avg Closing Trade (30 D): $.93M
Avg Closing Trade (90 D): $1.08M
Avg Closing Volume: 225.79K
       
News
Jul 17, 2024 @ 12:21 PM
ASML Reports Q2 Results, Joins Spirit Airlines And...
Source: Avi Kapoor
Jul 17, 2024 @ 10:03 AM
Why Bloom Energy Group Shares Are Trading Higher B...
Source: Avi Kapoor
Apr 8, 2024 @ 12:24 PM
Perion Network Cuts Sales Outlook, Joins Range Res...
Source: Avi Kapoor
Mar 21, 2024 @ 3:40 AM
Cathie Wood's Ark Invest Sells Another Tranche Of ...
Source: Benzinga Neuro
Mar 14, 2024 @ 3:41 AM
Cathie Wood's Ark Invest Sells Coinbase Shares As ...
Source: Benzinga Neuro
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.11 $-.01 $-.11
Diluted EPS $-.11 $-.01 $-.11
Revenue $ 201.32M $ 114.08M $ 201.32M
Gross Profit $ $ $
Net Income / Loss $ -20.96M $ -2.56M $ -20.96M
Operating Income / Loss $ -14.23M $ -1.45M $ -14.23M
Cost of Revenue $ $ $
Net Cash Flow $ 8M $ -1.85M $ 8M
PE Ratio